Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06828107 · ClinicalTrials.gov registry record
A Study to Evaluate the SENSE Device's Ability to Detect TBI
A clinical trial of Traumatic Brain Injury, sponsored by Sense Diagnostics.
- Recruiting
- Registry status
- 150
- Enrollment target
- 6
- Study locations
NCT06828107 is a study of Traumatic Brain Injury that is actively recruiting participants, run by Sense Diagnostics. The registered enrollment target is 150 participants, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (46% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT06828107, a study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Sense Diagnostics.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 6
- Study locations
Study Summary
The study population will consist of 3 mutually-exclusive sets of patients and subjects: * TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health. Research subjects ages 22 and older will be enrolled. All TBI patients must be monitored with the SENSE Device within 6 hours of a diagnostic head CT scan ordered by a treating clinician and within 24 hours of injury.
Conditions Studied
Interventions
- DEVICE SENSE device
Study Locations (6)
Texas
- UT Houston - Houston
- UTSA - San Antonio
Florida
- University of Florida - Gainesville
Ohio
- University of Cincinnati - Cincinnati
Pennsylvania
- University of Pittsburgh - Pittsburgh
South Carolina
- MUSC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06828107
The ClinicalTrials.gov registry entry for NCT06828107 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (46% lower). The listed sponsor is Sense Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which SENSE device is the first listed.
NCT06828107 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Texas, Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06828107 about?
NCT06828107 is a clinical study titled "A Study to Evaluate the SENSE Device's Ability to Detect TBI". The study population will consist of 3 mutually-exclusive sets of patients and subjects: * TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health. Research subjects ages 22 and older will be enrolled. All TBI patients must b...
What is the current status of trial NCT06828107?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-07-11. Estimated completion is 2026-06-30.
What conditions does trial NCT06828107 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT06828107?
The interventions under investigation include: SENSE device (DEVICE).
Who is sponsoring clinical trial NCT06828107?
This trial is sponsored by Sense Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06828107 being conducted?
This trial has 6 study locations across Florida, Ohio, Pennsylvania, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.